Table 3. Prevalence of 12-month WMH-CIDI/DSM-IV disorders in all sample and among herbal medicine (HM) users in community-based surveys in Japan and US^†.

	12-month prevalence of the disorder category in the total sample (%)	Prevalence of HM users among respondents with 12-month disorder category (%)	APOR§	95%CIs
Japan
Any anxiety disorders	4.9	6.4	23.6	(5.2-108.2)*
Any mood disorders	2.3‡	0.8‡	0.4	(0.0-4.4)
Any substance disorders	1.0	-	<0.001	(<0.001-<0.001)*
U.S.
Any anxiety disorders	18.5	9.0	2.7	(1.9-3.7)*
Any mood disorders	8.3‡	11.3‡	2.5	(1.7-3.7)*
Any substance disorders	3.8	8.5	2.4	(1.3-4.7)*

^†Samples were weighted to adjust for differential probabilities of selection and post-stratification to match the population distributions based on the cross-classification for sex and age.

^§Adjusted prevalence odds ratio (APOR) and the 95% confidence intervals (95%CIs) estimated by using multiple logistic regression adjusted for sex, age, education, marital status, employment, and other disorder categories.

^‡Part I sample, otherwise part II sample.

^-no cases.

^*Significant at the 0.05 level.